Sarepta Corp - SRPT Expected earnings per share growth for next year

Corporate company logo of sarepta.com (SRPT)

Geopolitical conflicts are hindering global clinical trials and the supply of biomaterials, yet the streamlined cold-chain logistics network of Sarepta Therapeutics, Inc. (SRPT) mitigates these risks. The target net income per share growth rate visualizes the result of this resilience, where the -95.60 mark serves as the current indicator. Such stability is bolstered by strategic alliances with pharma behemoths, which accelerate the commercialization of Duchenne muscular dystrophy therapy.

SRPT: Sarepta Therapeutics Expected earnings per share trend next year 07/04/2022 - 11/18/2026

Sarepta - analytical breakdowns and key metrics (SRPT)

Basic company analysis:SRPT, Sarepta Therapeutics Inc
Core merchandise of sarepta.com

Sarepta Therapeutics, Inc. (SRPT) specializes in developing gene therapies to combat rare muscle pathologies, mitigating risks through a diversified research portfolio. This indicator measures the expected earnings growth for the upcoming period, reflecting the current analyst consensus, which allows investors to assess capitalization potential via the company's forward EPS dynamics model.

Who Sarepta Therapeutics, Inc. competes with

TEM (Tempus) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year QGEN (Qiagen)|Earnings growth forecast for next year IONS|RGEN (Repligen) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year aviditybiosciences.com RNA|CRISPR (CRSP) - Expected net earnings per share growth next year|genedx.com - Earnings growth forecast for next year|Expected earnings per share trend next year RARE (ultragenyx.com)|BEAM: Earnings growth forecast for next year|TWST - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year 10x Genomics, Inc.|NTLA: Expected earnings per share trend next year|Expected earnings per share growth for next year STOK (Stoke Corp)|Consensus forecast of earnings per share growth for next year biolifesolutions.com|Earnings growth forecast for next year WVE (Wave Life Sciences Ltd)|Consensus forecast of earnings per share growth for next year Maze Therapeutics (MAZE)|SION: Expected earnings per share growth for next year|Consensus forecast of earnings per share growth for next year Prime Medicine Bio PRME|TSHA: Earnings growth forecast for next year|Projected earnings per share growth rate for next year QURE|Expected earnings per share growth for next year MGTX|Projected earnings per share growth rate for next year RGNX (REGENXBIO)|Earnings growth forecast for next year SLDB|OCGN - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year Pacific Biosciences of California PACB|BNTC: Projected earnings per share growth rate for next year|DSGN - Net earnings per share growth forecast for next year|RCKT: Net earnings per share growth forecast for next year|FDMT - Projected earnings per share increase next year|Expected net earnings per share growth next year Lexeo Therapeutics Inc. (LXEO)|Net earnings per share growth forecast for next year Korro Bio Inc.|Editas Medicine (EDIT) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Silence Therapeutics Inc. (SLN)|PRQR: Net earnings per share change forecast for next year|Earnings growth forecast for next year CDXS (codexis.com)|SGMO: Projected earnings per share growth rate for next year|NAUT: Expected earnings per share growth for next year|Expected net earnings per share growth next year metagenomi.co|Precision BioSciences, Inc. (DTIL) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Generation Bio Corp (GBIO)|Expected earnings per share growth for next year BOLD|exicuretx.com (XCUR) - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year IMNN (Celsion Corporation)|PHIO (Phio Pharmaceuticals Corp.) - Expected earnings per share trend next year|Earnings growth forecast for next year MBIO (Mustang Bio Corp)|Projected earnings per share increase next year RNAZ (TransCode Therapeutics)|BNGO - Net earnings per share growth forecast for next year|APDN: Net earnings per share growth forecast for next year|BLUE: Earnings growth forecast for next year|Expected earnings per share growth for next year ImmunoPrecise Antibodies|OMGA (Omega Therapeutics, Inc.) - Earnings growth forecast for next year|Singular Genomics (OMIC) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Regulus (RGLS)|SYRS (Syros Pharmaceuticals, Inc) - Expected earnings per share trend next year|Telesis Bio, Inc. - Expected earnings per share growth for next year|TCON: Projected earnings per share growth rate for next year|Unity Biotechnology Inc. - Earnings growth forecast for next year